Department of Hematology, Qilu Hospital, Shandong University, 107 West Wenhua Road, Jinan, Shandong 250012, P, R, China.
Biomark Res. 2013 Jul 18;1(1):23. doi: 10.1186/2050-7771-1-23.
The Notch signaling pathway plays a critical role in maintaining the balance between cell proliferation, differentiation and apoptosis, and is a highly conserved signaling pathway that regulates normal development in a context- and dose-dependent manner. Dysregulation of Notch signaling has been suggested to be key events in a variety of hematological malignancies. Notch1 signaling appears to be the central oncogenic trigger in T cell acute lymphoblastic leukemia (T-ALL), in which the majority of human malignancies have acquired mutations that lead to constitutive activation of Notch1 signaling. However, emerging evidence unexpectedly demonstrates that Notch signaling can function as a potent tumor suppressor in other forms of leukemia. This minireview will summarize recent advances related to the roles of activated Notch signaling in human lymphocytic leukemia, myeloid leukemia, stem cells and stromal microenvironment, and we will discuss the perspectives of Notch signaling as a potential therapeutic target as well.
Notch 信号通路在维持细胞增殖、分化和凋亡之间的平衡中起着关键作用,是一种高度保守的信号通路,以依赖于上下文和剂量的方式调节正常发育。 Notch 信号通路的失调被认为是各种血液恶性肿瘤的关键事件。 Notch1 信号似乎是 T 细胞急性淋巴细胞白血病 (T-ALL) 中的主要致癌触发因素,大多数人类恶性肿瘤已经获得了导致 Notch1 信号持续激活的突变。然而,新出现的证据出人意料地表明, Notch 信号在其他形式的白血病中可以作为一种有效的肿瘤抑制因子发挥作用。这篇小综述将总结有关激活的 Notch 信号在人类淋巴细胞白血病、髓样白血病、干细胞和基质微环境中的作用的最新进展,并将讨论 Notch 信号作为潜在治疗靶点的观点。